A phase II study of troglitazone, an activator of the PPARgamma receptor, in patients with chemotherapy-resistant metastatic colorectal cancer (Q44205075)
Jump to navigation
Jump to search
scientific article published in September 2002
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase II study of troglitazone, an activator of the PPARgamma receptor, in patients with chemotherapy-resistant metastatic colorectal cancer |
scientific article published in September 2002 |
Statements
1 reference
A phase II study of troglitazone, an activator of the PPARgamma receptor, in patients with chemotherapy-resistant metastatic colorectal cancer (English)
1 reference
1 reference
Bruce M Spiegelman
1 reference
Charles S Fuchs
1 reference
Matthew H Kulke
1 reference
George D Demetri
1 reference
David P Ryan
1 reference
Ramesh Shivdasani
1 reference
Jeffrey S Clark
1 reference
Haesook Kim
1 reference
Robert J Mayer
1 reference
1 September 2002
1 reference
1 reference
8
1 reference
5
1 reference
395-399
1 reference
Identifiers
1 reference
1 reference